Out of 38 IDH-wildtype anaplastic astrocytomas (71%) and 25 diffuse astrocytomas (72%), 27 (71%) and 18 (72%) respectively were reclassified as mol-GBMs due to the presence of key genetic features. The gene discussed is IDH2; the disease is diffuse astrocytoma.